Bionumerik Pharmaceuticals, Inc.
Records under this name other than patents Bionumerik Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Bionumerik Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,320,760 | Compositions and Methods of Use of Compounds to Increase Cancer Patient Survival Time Formerly held In force · Low confidence | In force | Low confidence | |
| US 9,023,805 | Increasing Cancer Patient Survival Time by Administration of Dithio-Containing Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 11,471,431 | Increasing cancer patient survival time by administration of dithio-containing compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,722,886 | Methods for the total chemical synthesis of enantiomerically-pure 7-(2′-trimethylsilyl)ethyl camptothecin Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,413,538 | Administration of karenitecin for the treatment of platinum and/or taxane chemotherapy-resistant or -refractory advanced ovarian cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,829,539 | Compounds and methods for reducing undesired toxicity of chemotherapeutic agents Formerly held Term ended Term ended Nov 1, 2025 · From the USPTO record | Term ended | Term ended Nov 1, 2025 | From the USPTO record |
| US 7,829,117 | Compounds and methods for reducing undesired toxicity of chemotherapeutic agents Formerly held Term ended Term ended Oct 28, 2025 · From the USPTO record | Term ended | Term ended Oct 28, 2025 | From the USPTO record |
| US 7,829,541 | Compounds and methods for reducing undesired toxicity of chemotherapeutic agents Formerly held Term ended Term ended Oct 28, 2025 · From the USPTO record | Term ended | Term ended Oct 28, 2025 | From the USPTO record |
| US 7,829,540 | Compounds and methods for reducing undesired toxicity of chemotherapeutic agents Formerly held Term ended Term ended Oct 27, 2025 · From the USPTO record | Term ended | Term ended Oct 27, 2025 | From the USPTO record |
| US 7,829,538 | Compounds and methods for reducing undesired toxicity of chemotherapeutic agents Formerly held Term ended Term ended Oct 26, 2025 · From the USPTO record | Term ended | Term ended Oct 26, 2025 | From the USPTO record |